"Culture eats strategy for breakfast."This principle has guided my leadership throughout my 25+ years in the pharmaceutical industry. I focus on aligning strategy, innovation, capabilities, and culture to drive exceptional results.As a senior commercial leader, I am recognized for building winning strategies, leading high-performing teams, and consistently delivering strong business results. My experience spans multiple therapeutic areas in both Canadian and UK markets. I cultivate an empowering environment where teams take ownership and achieve outstanding outcomes.Most recently, as Senior Director of the Innovative Medicines Business Unit at BMS, I led a business transformation to ensure the successful launches of key products in Cardiovascular, IBD, and Dermatology. This included designing a new go-to-market strategy, optimizing resource allocation, and enhancing operational efficiency. I also drove a cultural shift toward results orientation, accountability, and agility, which empowered the team to meet ambitious goals and deliver strong performance.Prior to BMS, I held director-level roles in sales and marketing at AstraZeneca and GSK, where I gained valuable experience across a range of therapeutic areas and successfully navigated challenges from late-stage lifecycle management to new product launches. These formative years honed my ability to craft winning strategies, drive executional excellence, and sharpen my leadership skills, shaping me into a well-rounded business leader.I thrive in environments that challenge the status quo and am passionate about building high-performing, engaged teams that deliver exceptional results.